ArticleJournal of veterinary pharmacology and therapeutics2014

Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.

A J Gonzales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.